Skip to main content
. 2011 Aug 12;118(15):4024–4035. doi: 10.1182/blood-2011-05-351346

Table 3.

PCALCL: therapies and results

Therapy References No. of patients CR, no. (%) Relapse rate, no. (%)
SE 8,21–25,27–29,36 53 27/27 (100) 19/44 (43)
RT 8,21–23,25,30–35 32 19/20 (95) 9/22 (41)
Multiagent chemotherapy 21,24,25,27,28,37,39–43,45,57,102,103 53 35/39 (90) 16/26 (62)